These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34987572)

  • 1. Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats.
    Hsieh TH; He XK; Liu HH; Chen JJ; Peng CW; Liu HL; Rotenberg A; Chen KT; Chang MY; Chiang YH; Chang PK; Kuo CW
    Neural Plast; 2021; 2021():1763533. PubMed ID: 34987572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson's Disease.
    Tsai WL; Chen HY; Huang YZ; Chen YH; Kuo CW; Chen KY; Hsieh TH
    Behav Neurol; 2019; 2019():4829572. PubMed ID: 31885725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early transcranial direct current stimulation treatment exerts neuroprotective effects on 6-OHDA-induced Parkinsonism in rats.
    Feng XJ; Huang YT; Huang YZ; Kuo CW; Peng CW; Rotenberg A; Juan CH; Pei YC; Chen YH; Chen KY; Chiang YH; Liu HH; Wu JX; Hsieh TH
    Brain Stimul; 2020; 13(3):655-663. PubMed ID: 32289694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Dopaminergic Neurons in Substantia Nigra are Required for Transcranial Magnetic Stimulation-Induced Motor Plasticity.
    Hsieh TH; Huang YZ; Rotenberg A; Pascual-Leone A; Chiang YH; Wang JY; Chen JJ
    Cereb Cortex; 2015 Jul; 25(7):1806-14. PubMed ID: 24451657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.
    Lee JY; Kim HS; Kim SH; Kim HS; Cho BP
    Tissue Eng Regen Med; 2020 Feb; 17(1):67-80. PubMed ID: 31970698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.
    Lee JY; Kim SH; Ko AR; Lee JS; Yu JH; Seo JH; Cho BP; Cho SR
    Brain Res; 2013 Nov; 1537():290-302. PubMed ID: 23998987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effects of repetitive transcranial magnetic stimulation with different high frequencies on motor functions in MPTP/probenecid induced Parkinsonism mouse models.
    Lyu Z; Xiao G; Xie D; Huang D; Chen Y; Wu C; Lai Y; Song Z; Huang L; Ming H; Jiang Y; Wang J; Chen R; Luo W
    Brain Behav; 2024 Jul; 14(7):e3605. PubMed ID: 38956819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Motor Cortical Electrical Stimulation Ameliorates 6-Hydroxydopamine-Induced Motor Dysfunctions and Exerts Neuroprotective Effects in a Rat Model of Parkinson's Disease.
    Kuo CW; Chang MY; Chou MY; Pan CY; Peng CW; Tseng HC; Jen TY; He XK; Liu HH; Nguyen TXD; Chang PK; Hsieh TH
    Front Aging Neurosci; 2022; 14():848380. PubMed ID: 35250550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent Theta Burst Stimulation Improves Motor and Behavioral Dysfunction through Modulation of NMDA Receptor Subunit Composition in Experimental Model of Parkinson's Disease.
    Zeljkovic Jovanovic M; Stanojevic J; Stevanovic I; Stekic A; Bolland SJ; Jasnic N; Ninkovic M; Zaric Kontic M; Ilic TV; Rodger J; Nedeljkovic N; Dragic M
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
    Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
    Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Sleeman IJ; Boshoff EL; Duty S
    Neuropharmacology; 2012 Dec; 63(7):1268-77. PubMed ID: 22971544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism.
    Cuevas-Carbonell SG; Vásquez-Celaya L; García-López D; Granados-Patrón D; García-Miss MDR; Álvarez-Cervera FJ; Mut-Martín M; Parra I; Mendieta L; Salgado H; Alamilla J; Cruz-Bojórquez R; Ávila-Escalante ML; Aranda-González II; Góngora-Alfaro JL
    Neuroscience; 2022 Dec; 507():79-98. PubMed ID: 36370934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
    Antunes MS; Ladd FVL; Ladd AABL; Moreira AL; Boeira SP; Cattelan Souza L
    Metab Brain Dis; 2021 Jan; 36(1):153-167. PubMed ID: 33057922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.
    Jamali-Raeufy N; Mojarrab Z; Baluchnejadmojarad T; Roghani M; Fahanik-Babaei J; Goudarzi M
    Metab Brain Dis; 2020 Mar; 35(3):539-548. PubMed ID: 32016817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease.
    Yang X; Song L; Liu Z
    Neuroreport; 2010 Mar; 21(4):268-72. PubMed ID: 20087233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
    Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-(4-Hydroxy-3-dimethoxybenzylidene)-thiazolidinone improves motor functions and exerts antioxidant potential in hemiparkinsonian rats.
    Ren Z; Ding H; Zhou M; Yang N; Liu Y; Chan P
    Behav Pharmacol; 2023 Feb; 34(1):68-77. PubMed ID: 36730023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.
    Park HJ; Lim S; Joo WS; Yin CS; Lee HS; Lee HJ; Seo JC; Leem K; Son YS; Kim YJ; Kim CJ; Kim YS; Chung JH
    Exp Neurol; 2003 Mar; 180(1):93-8. PubMed ID: 12668152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.